A discussion with Dr. Sanjay Kishore on trends in prescribing direct-acting antivirals (DAAs) to treat hepatitis C, and developing telehealth models to expand access to care.
See his recent article, National Prescribing Trends of Direct-Acting Antivirals for Hepatitis C.